| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.054 | 0.3 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.3 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | 0.053 | 0.3 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | -0.03 | 0.3 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | -0.037 | 0.3 |